Literature DB >> 34141055

Novel Small Molecule RNA m6A Demethylase AlkBH5 Inhibitors for Treating Cancer.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 34141055      PMCID： PMC8201485          DOI： 10.1021/acsmedchemlett.1c00102

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  6 in total

Review 1.  m6A mRNA methylation: A pleiotropic regulator of cancer.

Authors:  Srinivasan Muthusamy
Journal:  Gene       Date:  2020-01-30       Impact factor: 3.688

Review 2.  New sights in cancer: Component and function of N6-methyladenosine modification.

Authors:  Yiyang Hu; Sumin Wang; Jiao Liu; Yu Huang; Chunli Gong; Jingjing Liu; Yufeng Xiao; Shiming Yang
Journal:  Biomed Pharmacother       Date:  2019-12-30       Impact factor: 6.529

Review 3.  m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer.

Authors:  Huilin Huang; Hengyou Weng; Jianjun Chen
Journal:  Cancer Cell       Date:  2020-03-16       Impact factor: 31.743

Review 4.  Recent developments of small molecules targeting RNA m6A modulators.

Authors:  Jing Gu; Jun Xu; Qidong You; Xiaoke Guo
Journal:  Eur J Med Chem       Date:  2020-04-15       Impact factor: 6.514

Review 5.  N6-methyladenosine RNA modification in cancer therapeutic resistance: Current status and perspectives.

Authors:  Zhijie Xu; Bi Peng; Yuan Cai; Geting Wu; Jinzhou Huang; Ming Gao; Guijie Guo; Shuangshuang Zeng; Zhicheng Gong; Yuanliang Yan
Journal:  Biochem Pharmacol       Date:  2020-10-02       Impact factor: 5.858

Review 6.  Epigenetic Regulation of m6A Modifications in Human Cancer.

Authors:  Wei Zhao; Xiaoqian Qi; Lina Liu; Shiqing Ma; Jingwen Liu; Jie Wu
Journal:  Mol Ther Nucleic Acids       Date:  2019-11-29       Impact factor: 8.886
  6 in total
  3 in total

Review 1.  m6A modification: recent advances, anticancer targeted drug discovery and beyond.

Authors:  Li-Juan Deng; Wei-Qing Deng; Shu-Ran Fan; Min-Feng Chen; Ming Qi; Wen-Yu Lyu; Qi Qi; Amit K Tiwari; Jia-Xu Chen; Dong-Mei Zhang; Zhe-Sheng Chen
Journal:  Mol Cancer       Date:  2022-02-14       Impact factor: 27.401

Review 2.  Methyladenosine Modification in RNAs: From Regulatory Roles to Therapeutic Implications in Cancer.

Authors:  Xiaolin Qu; Yongqiu Zhang; Xianzheng Sang; Ding Ren; Hong Zhao; Stephen T C Wong
Journal:  Cancers (Basel)       Date:  2022-06-29       Impact factor: 6.575

Review 3.  The emerging therapeutic target of dynamic and reversible N6-methyladenosine modification during cancer development.

Authors:  Shougeng Liu; Sihong Chen; Chengfang Tang; Yingxi Zhao; Wei Cui; Lina Jia; Lihui Wang
Journal:  Front Oncol       Date:  2022-09-26       Impact factor: 5.738
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.